MARTELL RON 4
4 · Jasper Therapeutics, Inc. · Filed Mar 20, 2023
Insider Transaction Report
Form 4
MARTELL RON
DirectorPresident, CEO and Director
Transactions
- Award
Stock Option (right to buy)
2023-03-17+500,000→ 500,000 totalExercise: $1.87Exp: 2033-03-17→ Voting Common Stock (500,000 underlying)
Footnotes (1)
- [F1]1/4th of the shares subject to the option shall vest on March 3, 2024, and 1/48th of the shares subject to the option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.